UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8265 Cr | ₹1102 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.22 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | -4.51% | -5.32% |
| 6 Month | -8.21% | -9.28% |
| 1 Year | 2.33% | 1.82% |
| 3 Year | 20.55% | 22.65% |
| 5 Year | 14.16% | 14.1% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | -5.53% | -7.35% |
| 1 Year | -7.63% | -8.9% |
| 3 Year | 10.96% | 13.11% |
| 5 Year | 13.58% | 14.71% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 16.54% | 11.5% |
| 3 Year | 21% | 16.6% |
| 5 Year | 20.33% | 14.8% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 1.01% | 1.1% |
| Beta | 0.87% | 0.9% |
| Alpha | 1.33% | 2.92% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 3.47 | 5.11 |
| Mid Cap | 34.55 | 35.7 |
| Small Cap | 29.97 | 39.34 |
| Large Cap | 32.01 | 19.85 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 2.63 | 0.6 |
| Healthcare | 97.37 | 98.42 |
| Basic Materials | - | 0.98 |
Top Comparisons
HDFC Flexi Cap Fund - Growth Plan
3Y Returns21.78%
UTI Flexi Cap Fund - Growth Option
3Y Returns10.87%
HDFC Banking and PSU Debt Fund - Growth Option
3Y Returns7.17%
UTI Banking & PSU Fund- Regular Plan - Growth Option
3Y Returns7.21%
Nippon India Small Cap Fund - Growth Plan - Bonus Option
3Y Returns%
HSBC Small Cap Fund Regular Growth
3Y Returns16.16%
Sundaram Liquid Fund (G)
3Y Returns6.86%
Kotak Liquid Regular Plan Growth
3Y Returns6.18%